title: Successful control of scleroderma myocarditis using a combination of cyclophosphamide and methylprednisolone.
authors.forename: J
authors.initials: J
authors.lastname: Stack
authors.forename: P
authors.initials: P
authors.lastname: McLaughlin
authors.forename: C
authors.initials: C
authors.lastname: Sinnot
authors.forename: M
authors.initials: M
authors.lastname: Henry
authors.forename: P
authors.initials: P
authors.lastname: MacEneaney
authors.forename: A
authors.initials: A
authors.lastname: Eltahir
authors.forename: S
authors.initials: S
authors.lastname: Harney
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use*; D018450:Disease Progression; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D009205:Myocarditis / Q000188:drug therapy* / Q000209:etiology; D045743:Scleroderma, Diffuse / Q000150:complications / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D008775:Methylprednisolone